Feb 12 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved labeling changes to six menopause hormone therapies to remove references to risks of cardiovascular disease, ...
The FDA recently revised its approach to beverage labels in terms of artificial colors, while also approving two new natural color solutions. Kathleen Sanzo with Morgan Lewis details how this will ...
Primary CNS lymphoma is a rare and aggressive cancer with no FDA-approved treatments specific to the disease. While some ...
The Well News on MSN
FDA approves labeling changes to hormone therapy products
WASHINGTON - The Food and Drug Administration has approved changes to the labeling of six hormone therapy products used to ...
The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.
Exposure to the product "may cause temporary or medically reversible adverse health consequences," according to the FDA.
The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
The U.S. Food and Drug Administration (FDA) started 2025 with new guidance on non-listed food allergens after detailing requirements CPG companies must follow to label the top nine allergens in a ...
Federal law requires every prescription drug to include a document describing dosing guidelines, contraindications, results ...
The Food and Drug Administration (FDA) has placed two major retail chains under regulatory scrutiny after inspections found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results